We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
-1.41%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$84.7M
AUM Growth
-$13.5M
Cap. Flow
-$7.95M
Cap. Flow %
-9.38%
Top 10 Hldgs %
56.12%
Holding
79
New
15
Increased
14
Reduced
18
Closed
21

Top Buys

Rank Stock Value
1
IRMD icon
iRadimed
IRMD
+$3.43M
2
CYNO
Cynosure, Inc. Class A
CYNO
+$1.47M
3
LPSN icon
LivePerson
LPSN
+$1.37M
4
PCYO icon
Pure Cycle
PCYO
+$1.12M
5
SILC icon
Silicom
SILC
+$1.03M

Top Sells

Rank Stock Value
1
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$2.95M
2
ARCT icon
Arcturus Therapeutics
ARCT
+$2.68M
3
BKNG icon
Booking.com
BKNG
+$1.68M
4
FLNA
Filana Therapeutics
FLNA
+$1.6M
5
CPRX
Catalyst Pharmaceutical
CPRX
+$1.52M

Sector Composition

Rank Sector Weight
1 Healthcare 44.42%
2 Technology 19.14%
3 Utilities 9.4%
4 Financials 8.41%
5 Communication Services 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SANW
26
DELISTED
S&W Seed Co
SANW
$1.12M 1.32%
13,892
-6,521
-32% -$730K
P
27
DELISTED
Pandora Media Inc
P
$1.02M 1.2%
42,300
-7,600
-15% -$202K
CKSW
28
DELISTED
CLICKSOFTWARE TECH LTD
CKSW
$1.02M 1.2%
126,700
– –
CUTR
29
DELISTED
Cutera, Inc.
CUTR
$958K 1.13%
+94,700
New +$940K
TPST icon
30
Tempest Therapeutics
TPST
$17.9M
$922K 1.09%
19
– –
ALT icon
31
Altimmune
ALT
$630M
$892K 1.05%
+1,667
New +$872K
ENVI
32
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$803K 0.95%
435,322
– –
ELOS
33
DELISTED
Syneron Medical Ltd
ELOS
$713K 0.84%
+71,300
New +$725K
CYNI
34
DELISTED
CYAN INC COM
CYNI
$691K 0.82%
220,699
+38,000
+21% +$141K
BCPC
35
Balchem Corp
BCPC
$5.67B
$554K 0.65%
+9,800
New +$522K
MNDT
36
DELISTED
Mandiant, Inc. Common Stock
MNDT
$550K 0.65%
18,000
+10,900
+154% +$361K
IPHI
37
DELISTED
INPHI CORPORATION
IPHI
$448K 0.53%
+31,300
New +$455K
SQNS
38
Sequans Communications SA
SQNS
$44.3M
$444K 0.52%
2,250
– –
CLRB icon
39
Cellectar Biosciences
CLRB
$24M
$389K 0.46%
+6
New +$518K
ELNK
40
DELISTED
EarthLink Holdings Corp.
ELNK
$340K 0.4%
+99,700
New +$391K
SMSI icon
41
Smith Micro Software
SMSI
$16.5M
$180K 0.21%
1,268
+768
+154% +$127K
RKUS
42
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$154K 0.18%
11,500
– –
MWV
43
DELISTED
MEADWESTVACO CORP
MWV
$151K 0.18%
3,700
– –
MCUR
44
DELISTED
Macrocure Ltd.
MCUR
$141K 0.17%
+20,000
New +$168K
SLB icon
45
SLB Ltd
SLB
$81.6B
$122K 0.14%
1,200
+500
+71% +$54.5K
CP icon
46
Canadian Pacific Kansas City
CP
$82.5B
$119K 0.14%
2,875
– –
SRCI
47
DELISTED
SRC Energy Inc
SRCI
$119K 0.14%
9,800
-2,000
-17% -$24.9K
LNG icon
48
Cheniere Energy
LNG
$58B
$112K 0.13%
1,400
– –
LMNR icon
49
Limoneira
LMNR
$246M
$104K 0.12%
4,400
-1,100
-20% -$25.3K
LAYN
50
DELISTED
Layne Christensen Co
LAYN
$102K 0.12%
+10,500
New +$119K
1
2
3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Sophrosyne Capital held 79 positions worth $84.7M, down 14% from $98.2M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sophrosyne Capital withdrew a net $7.95M in Q3 2014, closing 21 positions and reducing 18 holdings. Its most notable exit was Booking.com, an estimated $1.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Technology and Utilities.

Against the trend, Sophrosyne Capital opened a new position in iRadimed worth $2.65M.

  • Sophrosyne Capital's largest Q3 2014 buy was iRadimed: 378,771 shares worth $2.65M.
  • Sophrosyne Capital added most to Pure Cycle in Q3 2014, an estimated $1.12M increase.
  • Sophrosyne Capital's biggest Q3 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $2.95M.
  • Sophrosyne Capital fully exited Booking.com in Q3 2014, selling an estimated $1.68M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $84.7M portfolio in Q3 2014.
  • Sophrosyne Capital opened 15 new positions and closed 21 in Q3 2014.
  • Sophrosyne Capital's portfolio value fell 14% quarter-over-quarter to $84.7M.

Based on Sophrosyne Capital's 13F filing for Q3 2014, filed 14 Nov 2014.